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Abstract
A large number of fatigue scales exist and there is no consensus on which fatigue measuring scales
that are most appropriate for use in assessment of fatigue in different diseases. We aimed to
describe the use of fatigue scales in studies of disease-related fatigue during the last three decades.
We searched databases from 1975 to 2004 for original studies reporting on disease-related fatigue
and extracted information on method used to assess fatigue, diseases under study and year of
publication. A total of 2285 papers reported measures of fatigue in chronic non-acute diseases of
which 80% were published during the last decade. We identified 252 different ways to measure
fatigue, of which 150 were use only once. Multi-symptom scales (n = 156) were used in 670 studies,
while 71 scales specifically designed to measure fatigue were applied in 416 studies. The majority
of these studies used scales with a multidimensional approach to fatigue, and most studies used
scales that were disease-specific or only applied to few different diseases. Research in disease-
related fatigue has increased exponentially during the last three decades, even if we adjust for the
general increase in publishing activity. The number of scales has also increased and the majority of
scales were developed for specific diseases. There is need for measure instruments with different
sizes and dimensionality, and due to ceiling and floor effects, the same scale may not be useful for
patients with different severity of fatigue. However, since fatigue is an unspecific symptom there
should not be need for adopting disease specific fatigue scales for each individual disease. There
may be differences in characteristics of fatigue between diseases and generic measurement
instruments may facilitate documentation of such differences, which may be of clinical importance.
Review
Fatigue may be a clinically important, although subjective
and quite unspecific characteristic of some chronic dis-
eases, and major textbooks list diseases from different
medical specialities like multiple sclerosis, heart failure,
liver disease, adrenal insufficiency, anemia, renal failure,
thyrotoxicosis, systemic lupus erythematosus, and any
malignant disease [1-3]. Fatigue is also a core symptom in
depression [4]. Although we generally know little of etiol-
ogy of fatigue, we do know that several biological factors
exists, e.g. anemia and toxic treatment effects, as well as
psychological factors. The word fatigue originate from the
experience in healthy individuals, but interview based
studies have revealed that even though patients label their
sensation as fatigue, they often find it qualitatively very
different from that fatigue they experienced before they
Published: 27 February 2007
Health and Quality of Life Outcomes 2007, 5:12 doi:10.1186/1477-7525-5-12
Received: 24 November 2006
Accepted: 27 February 2007
This article is available from: http://www.hqlo.com/content/5/1/12
© 2007 Hjollund et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Health and Quality of Life Outcomes 2007, 5:12 http://www.hqlo.com/content/5/1/12
Page 2 of 5
(page number not for citation purposes)
became sick [5]. Such findings indicate that fatigue may
not always be sufficiently described as a simple contin-
uum from no fatigue to severe fatigue, and a multidimen-
sional approach has been suggested, including e.g.
physical, cognitive, emotional and functional axes [6].
Fatigue may have impact on quality of life, and fatigue
questions have been included in many quality of life scales
[6].
Fatigue scales have recently been reviewed elsewhere
[6,7]. Dittner et al described and evaluated a number of
30 different scales [6], and concluded that further valida-
tion is needed for all scales and that no scale is appropri-
ate for measuring fatigue in all disease groups. Since there
is little consensus on which scale possess the most attrac-
tive properties, it may be useful to know which scales are
actually used to measure fatigue in research of different
diseases. The purpose of the present paper is to describe
the use of fatigue questionnaires in studies of disease-
related fatigue during the last three decades.
Methods
We searched MEDLINE and PsycINFO for studies report-
ing on disease-related fatigue in the period 1975 to 2004.
The search was last updated February 2004. MEDLINE
was searched using the MeSH terms 'fatigue' or 'asthenia',
supplemented with a free text search for the terms
'fatigue', 'asthenia' or 'tiredness' occurring together with
the MeSH terms 'questionnaires', 'health surveys', 'epide-
miologic studies', or 'quality of life'. The PsycINFO data-
base was searched for articles with the descriptor 'fatigue'
occurring together with classification codes indicating
somatic, functional or psychiatric disease (32xx, 3361,
3363, 337x or 338x). Several check-ups in reference lists
suggested that inclusion of other databases would only
result in few additional peer-reviewed studies of fatigue in
populations of patients.
References without abstract and articles written in non-
English language were excluded. All references and
abstracts were imported to a database and the following
information was extracted from the abstract: method used
to assess fatigue, disease(s) under study and year of publi-
cation. If it was not possible to extract this information
from the abstract, the full-text paper was reviewed. Ad hoc
constructed questions and review of medical records were
grouped together (ad hoc methods), so was one-item
questions used to assess acute treatment side effects. All
original studies in adult populations of patients with spec-
ified non-acute disease were included in the analyses.
Results
A total of 2285 papers reporting measures of fatigue in
somatic and psychiatric diseases were published between
1975 and 2004. An exponential increase in number of
fatigue studies was observed; thus 80% of the studies were
published during the last ten years of the period (Fig 1).
Ad hoc methods and simple one-item questions to meas-
ure acute side effects dominated until 1990 (Fig 1). From
the beginning of the 80'ies, quality of life scales and other
multi-symptom scales were introduced, while scales spe-
cifically designed to measure fatigue have mainly been in
use the last decade (Fig 1). We identified no less than 252
different methods to assess fatigue of which 150 were
used only once. Overall, the most frequent method was
ad-hoc constructed questions or retrospective review of
medical records, which was used in 669 studies (Table 1).
In 670 studies fatigue was measured by one of 157 multi-
symptom scales as one of several domains like the generic
questionnaire  Short Form-36 [8] or the cancer specific
EORTC QLQ-C30 [9]. In total 71 scales focusing specifi-
cally on fatigue was identified in 416 studies (Table 2).
Characteristics of the most frequent used fatigue scales are
shown in Table 2. The majority of these studies used
fatigue scales with a multidimensional approach, typically
divided in a physical and a mental part, where the latter
may be divided in a cognitive and an emotional part.
Some measure instruments also rate functioning (Table
2). Most fatigue scales were developed to measure fatigue
in specific diseases, most often cancer, and only few scales
have been applied to a wider range of diseases (Table
2).We located 67 studies with a qualitative approach,
most often in studies of malignancies (n = 20) and rheu-
matologic diseases (n = 10).
Studies of disease related fatigue by year of publication by  method of fatigue assessment Figure 1
Studies of disease related fatigue by year of publication by 
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Discussion
We located 2285 peer-reviewed papers that reported
measures of fatigue in non-acute medical and psychiatric
diseases using 252 different ways to measure fatigue.
Although we only searched MEDLINE and PsycINFO, we
found that inclusion of other databases would only result
in few additional peer-reviewed studies of fatigue in pop-
ulations of patients. We believe our results reflect the way
fatigue is assessed in chronic diseases. Two important
findings may be highlighted: the large number of studies
on disease-related fatigue and the large number of differ-
ent methods applied to assess disease-related fatigue.
Research in disease-related fatigue has increased exponen-
tially during the last three decades, even if we adjust for
the general increase in publishing activity. The true
number of studies with fatigue assessments is even higher
than reported here, since any application of e.g. SF-36 and
even SF-12 involves questions on fatigue, even though
results may only be reported as a summary measure that
includes contributions from other domains. Also the
number of different scales has increased, although the
inappropriate uses of homemade ad-hoc questionnaires
seem to decline.
The majority of scales were developed for specific dis-
eases. As a consequence it is difficult to assess and analyze
differences between different diseases in the occurrence
and characteristics of fatigue. Dittner et all argue that the
different manifestations and the wide range of mecha-
nisms probably underlying fatigue makes it unlikely that
any one fatigue scale will ever be appropriate fore measur-
ing fatigue in all disease groups [6].
It is evident that due to ceiling and floor effects, the same
scale may not be useful for both e.g. the terminal cancer
patients and the patient with a newly diagnosed multiple
sclerosis with subtle symptoms. There may indeed also be
need for measure instruments with different sizes and
dimensionality. However, since the fatigue symptom is
notoriously unspecific, one might question the reason for
adopting disease specific fatigue scales for each individual
disease. There may be differences in characteristics of
fatigue between diseases, although we unfortunately
know little about it. Use of generic measurement instru-
ments may facilitate the documentation of such differ-
ences, which may be of scientific as well as clinical
importance.
Conclusion
Research in disease-related fatigue has increased rapidly
during the last decades. The number of scales has also
increased, but the majority of scales were developed for
specific diseases. However, since fatigue is an unspecific
symptom there is no need for developing disease specific
fatigue scales for each individual disease. True enough,
there may be differences in characteristics of fatigue
between diseases, but only generic fatigue scales may facil-
itate documentation of such differences.
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Table 1: Most frequently used questionnaires by type of scale
Questionnaire Number of 
studies
Ad-hoc methods 669
Acute side effect assessment question 658
Multi-symptom scales 670
EORCT QLQ-C30 [9] 131
Short Form-36 [8] 100
Profile of Mood States [10] 88
Chronic Respiratory Disease Questionnaire [11] 20
Sickness Impact Profile [12] 16
Fibromyalgia Impact Questionnaire [13] 11
Symptom Distress Scale [14] 11
Kidney Disease Questionnaire [15] 10
Other multi-symptom questionnaires (n = 148) 283
Fatigue specific scales 416
Fatigue Severity Scale [16] 68
Fatigue Questionnaire/Fatigue Rating Scale/
Chalder Fatigue Scale [17]
48
Multidimensional Fatigue Inventory [18] 35
Piper Fatigue Scale [19] 23
Functional Assessment of Cancer Therapy-
Fatigue Scale [20]
22
Fatigue Impact Scale/Fisk Fatigue Severity Score 
[21]
22
Christensen-Kehlet Ordinal Fatigue Scale [22] 21
Checklist Individual Strength [23] 16
Maastricht Questionnaire (vital exhaustion) [24] 13
Brief Fatigue Inventory [25] 11
Visual Analogue-Fatigue [26] 11
Fatigue Symptom Inventory [27] 10
Multidimensional Assessment of Fatigue [28] 10
Other fatigue-specific questionnaires (n = 58) 106H
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Table 2: Characteristics of the most frequent used specific fatigue scales
Scale Proposed dimensions Items Time lag Use by decade Most frequent ICD-10 groups (n) Most frequent diseases (n)
Fatigue Severity Scale [16] 1 (mixed) 9 Not stated 80': 1
90' :26
00': 41
Neurology (33)
Rheumatology (12)
Multiple sclerosis (23)
SLE (9)
Mb Parkinson (7)
Fatigue Questionnaire [17] Physical fatigue
Mental fatigue
11 Not stated 80': 1
90': 15
00': 32
Symptoms (13)
Infections (9)
Malignancies (9)
CFS (13)
Mb Hodgkin (5)
HIV (4)
Multidimensional Fatigue Inventory[18] General fatigue
Physical fatigue
Reduced activity
Reduced motivation
Mental fatigue
20 Previous days 90': 14 00': 21 Malignancies (22)
Neurologic (4)
Mixed cancer patients (13)
Breast cancer (3)
Piper Fatigue Scale [19] Sensory
Affective meaning
Cognitive/mood
Behavioral/severity
76 Now 90': 13
00': 10
Malignancies (18)
Infections (2)
Breast cancer (10)
HIV (2)
Functional Assessment of Cancer Therapy – Fatigue [20] 1 13 Past week 90': 2
00': 20
Malignancies (22) Mixed cancer patients (18)
Fatigue Impact Scale [21] Cognitive
Physical
Psychosocial
40 Past month 90': 5
00': 17
Neurologic (13)
Infections (4)
Multiple sclerosis (13)
Hepatitis C (4)
Christensen-Kehlet [22] 1 (function) 1 Now 80': 8
90': 12
00': 1
Post surgery (20) Abdominal surgery (20)
Checklist Individual Strength [23] Experience of fatigue
Concentration
Motivation
Physical activity
20 Past 2 weeks 90': 5
00': 11
Symptoms (6)
Malignancies (5)
CFS (6)
Multiple sclerosis (2)
Maastricht Questionnaire [24] 1 21 Now 80': 1
90': 7
00': 5
Cardiovascular (12) AMI (7)
Coronar artery sclerosis (5)
Brief Fatigue Inventory [25] 1 9 Now/24 hours 90': 1
00': 10
Malignancies (11) Mixed cancer patients (7)
Visual Analogue Scale-Fatigue [26] Energy
Fatigue
18 Now 90': 5
00': 6
Malignancies (5) Mixed cancers (3)
Fatigue Symptom Inventory [27] Intensity
Duration
Impact on quality of life
13 Now/past week 90': 5
00': 5
Malignancies (10) Breast cancer (6)
Mixed cancer patients (4)
Multidimensional Assessment of Fatigue [28] Degree
Severity
Distress
Impact on activities
Timing
16 Past week 90': 4
00': 6
Malignancies (5)
Rheumatological (3)
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